➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Boehringer Ingelheim
Express Scripts
Moodys
Mallinckrodt

Last Updated: May 25, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Abediterol


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Abediterol?

Abediterol is an investigational drug.

There have been 4 clinical trials for Abediterol. The most recent clinical trial was a Phase 1 trial, which was initiated on June 1st 2016.

The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive, and Lung Diseases. The leading clinical trial sponsors are AstraZeneca, Parexel, and [disabled in preview].

There are forty-seven US patents protecting this investigational drug and seven hundred and forty-eight international patents.

Recent Clinical Trials for Abediterol
TitleSponsorPhase
Relative Bioavailability Study With Abediterol Administered Via Three Different Inhalation Devices in Healthy Volunteers.ParexelPhase 1
Relative Bioavailability Study With Abediterol Administered Via Three Different Inhalation Devices in Healthy Volunteers.AstraZenecaPhase 1
To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled CorticosteroidsAstraZenecaPhase 1

See all Abediterol clinical trials

Clinical Trial Summary for Abediterol

Top disease conditions for Abediterol
Top clinical trial sponsors for Abediterol

See all Abediterol clinical trials

US Patents for Abediterol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Abediterol   Start Trial Dosage and formulation Almirall, S.A. (Barcelona, ES)   Start Trial
Abediterol   Start Trial Pyrazolyl-substituted heteroaryls and their use as medicaments Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)   Start Trial
Abediterol   Start Trial Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases Vertex Pharmaceuticals Incorporated (Boston, MA)   Start Trial
Abediterol   Start Trial Inhalator and capsule for an inhalator Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)   Start Trial
Abediterol   Start Trial Modulators of cystic fibrosis transmembrane conductance regulator Vertex Pharmaceuticals Incorporated (Boston, MA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Abediterol

Drugname Country Document Number Estimated Expiration Related US Patent
Abediterol Argentina 070835 2028-03-13   Start Trial
Abediterol Australia 2009224895 2028-03-13   Start Trial
Abediterol Brazil PI0905775 2028-03-13   Start Trial
Abediterol Canada 2716724 2028-03-13   Start Trial
Abediterol Chile 2009000602 2028-03-13   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Express Scripts
Harvard Business School
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.